+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Telecare Market Size, Share & Trends Analysis Report by Type (Activity Monitoring, Remote Medication Management), by Region (North America, Europe, Asia Pacific, Latin America, MEA), and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 118 Pages
  • February 2022
  • Region: Global
  • Grand View Research
  • ID: 5553311
The global telecare market size is expected to reach USD 6.3 billion by 2030. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. Telecare provides services mainly to the vulnerable and geriatric people for immediate contact with someone for help in case of any emergency. In addition, the increasing development of new technology from telephones to online virtual visits has shaped the face of modern health care services. Moreover, the growing adoption of digital health services to extend patients' access to care, remotely monitor risks, health conditions, or any early warning signs is anticipated to fuel market growth over forecast years.



The activity monitoring segment dominated the type segment with a revenue share of 51.3% in 2021. This revenue share of the segment is attributed due to the growing adoption of telecare services for remote activity monitoring and assisting the elderly. The increasing number of geriatric population and growing preference to adopt smart remote assistants or personal alarms to monitor unusual behavior patterns or any warning signs of falls for the elderly are among the major factors anticipated to drive the segment growth over the forecast years. In addition, a growing number of telecare centers monitoring the social and lifestyle activity of a physically disabled or elderly individual 24/7 and providing appropriate help such as remote medical assistance is further supporting the growth of the market.

North America accounted for the highest revenue share of 50.5% by region in 2021 owing to the growing adoption of new technology and increasing penetration of the internet. In addition, the rising geriatric population in the U.S and increasing adoption of digital health care platforms for daily activity tracking and remote medication management for the elderly is anticipated to drive the market in this region over the forecast period. Furthermore, the presence of a larger number of telecare service providers further fuels market growth in this region.

Furthermore, the COVID-19 pandemic upsurge the adoption of digital health platforms including telecare. The increasing fear of life-threatening coronavirus infection in 2020 increases the adoption of remote patient monitoring and activity tracking platforms. Increasing promotion for remote patient monitoring using mobile technology by the government organizations for digital health management and the increasing use of mobile applications are among the major factors that further boosted telecare adoption in 2020. For instance, as per world economic forum data, there is a growth of 46% of the health and fitness app download during pandemic which thereby supported to market growth in 2020.

Telecare Market Report Highlights

  • The market size is anticipated to be valued at USD 6.3billion by 2030, owing to an increasing elderly population and growing preference for digital health services to extend patients access to care, remotely monitor risks, and health conditions.
  • The activity monitoring segment dominated the market in 2021, owing to the growing adoption of telecare services for remote activity monitoring and providing assistance to the elderly.
  • North America dominated the market and accounted for the largest revenue share of 50.5% in 2021, owing to the rising geriatric population in the U.S and increasing adoption of telecare platforms for daily activity tracking and remote medication management for elderly.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Telecare Market

What is the estimated value of the Global Telecare Market?

The Global Telecare Market was estimated to be valued at $4.1 Billion in 2022.

What is the growth rate of the Global Telecare Market?

The growth rate of the Global Telecare Market is 5.5%, with an estimated value of $6.3 Billion by 2030.

What is the forecasted size of the Global Telecare Market?

The Global Telecare Market is estimated to be worth $6.3 Billion by 2030.

Who are the key companies in the Global Telecare Market?

Key companies in the Global Telecare Market include Abbott, Johnson and Johnson, Astrazeneca plc, Roche, Novartis, Bristol, Myers Squibb, GlaxoSmithKline plc, Merck and Co. and Pfizer.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Type
2.2.2 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration & Growth Prospect Mapping
3.3 Marker Driver Analysis
3.4 Market Restraint Analysis
3.5 Telecare market: Industry Analysis Tools
3.5.1 Porter’s five forces analysis
3.5.2 PESTEL Analysis
3.6 COVID-19 Impact
Chapter 4 Telecare market: Type Analysis
4.1 Telecare Type Market Share Analysis, 2021 & 2030
4.2 Telecare Type Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analysis, 2016 to 2030 for the Type Segment
4.3.1 Activity Monitoring
4.3.1.1 Activity Monitoring market, 2016-2030 (USD Million)
4.3.2 Remote Medication Management
4.3.2.1 Remote Medication Management market, 2016-2030 (USD Million)
Chapter 5 Telecare market: Regional Analysis
5.1 Telecare Regional Market Share Analysis, 2021 & 2030
5.2 Telecare Regional Market: Segment Dashboard
5.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.4 Market Size, & Forecasts, and Trend Analysis, 2016 to 2030
5.4.1 North America
5.4.1.1 North America Telecare market, 2016-2030 (USD Million)
5.4.1.1.1 U.S.
5.4.1.1.1.1 U.S. Telecare market, 2016-2030 (USD Million)
5.4.1.1.2 Canada
5.4.1.1.2.1 Canada Telecare market, 2016-2030 (USD Million)
5.4.2 Europe
5.4.2.1 Europe Telecare market, 2016-2030 (USD Million)
5.4.2.1.1 U.K.
5.4.2.1.1.1 U.K. Telecare market, 2016-2030 (USD Million)
5.4.2.1.2 Germany
5.4.2.1.2.1 Germany Telecare market, 2016-2030 (USD Million)
5.4.2.1.3 France
5.4.2.1.3.1 France Telecare market, 2016-2030 (USD Million)
5.4.2.1.4 Italy
5.4.2.1.4.1 Italy Telecare market, 2016-2030 (USD Million)
5.4.2.1.5 Spain
5.4.2.1.5.1 Spain Telecare market, 2016-2030 (USD Million)
5.4.2.1.6 Russia
5.4.2.1.6.1 Russia Telecare market, 2016-2030 (USD Million)
5.4.3 Asia Pacific
5.4.3.1 Asia Pacific Telecare market, 2016-2030 (USD Million)
5.4.3.1.1 Japan
5.4.3.1.1.1 Japan Telecare market, 2016-2030 (USD Million)
5.4.3.1.2 China
5.4.3.1.2.1 China Telecare market, 2016-2030 (USD Million)
5.4.3.1.3 India
5.4.3.1.3.1 India Telecare market, 2016-2030 (USD Million)
5.4.3.1.4 Australia
5.4.3.1.4.1 Australia Telecare market, 2016-2030 (USD Million)
5.4.3.1.5 South Korea
5.4.3.1.5.1 South Korea Telecare market, 2016-2030 (USD Million)
5.4.3.1.6 Singapore
5.4.3.1.6.1 Singapore Telecare market, 2016-2030 (USD Million)
5.4.4 Latin America
5.4.4.1 Latin America Telecare market, 2016-2030 (USD Million)
5.4.4.1.1 Brazil
5.4.4.1.1.1 Brazil Telecare market, 2016-2030 (USD Million)
5.4.4.1.2 Mexico
5.4.4.1.2.1 Mexico Telecare market, 2016-2030 (USD Million)
5.4.4.1.3 Argentina
5.4.4.1.3.1 Argentina Telecare market, 2016-2030 (USD Million)
5.4.5 Middle East and Africa (MEA)
5.4.5.1 MEA Telecare market, 2016-2030 (USD Million)
5.4.5.1.1 South Africa
5.4.5.1.1.1 South Africa Telecare market, 2016-2030 (USD Million)
5.4.5.1.2 Saudi Arabia
5.4.5.1.2.1 Saudi Arabia Telecare market, 2016-2030 (USD Million)
5.4.5.1.3 UAE
5.4.5.1.3.1 UAE Telecare market, 2016-2030 (USD Million)
Chapter 6 Competitive Analysis
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
6.3 Company Market Position Analysis
6.4 Company Profiles
6.4.1 Abbott
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Product benchmarking
6.4.1.4 Strategic initiatives
6.4.2 Johnson and Johnson
6.4.2.1 Company overview
6.4.2.2 Financial performance
6.4.2.3 Product benchmarking
6.4.2.4 Strategic initiatives
6.4.3 AstraZeneca PLC
6.4.3.1 Company overview
6.4.3.2 Financial performance
6.4.3.3 Product benchmarking
6.4.3.4 Strategic initiatives
6.4.4 Roche
6.4.4.1 Company overview
6.4.4.2 Financial performance
6.4.4.3 Product benchmarking
6.4.4.4 Strategic initiatives
6.4.5 Novartis
6.4.5.1 Company overview
6.4.5.2 Financial performance
6.4.5.3 Product benchmarking
6.4.5.4 Strategic initiatives
6.4.6 Bristol-Myers Squibb
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Product benchmarking
6.4.6.4 Strategic initiatives
6.4.7 GlaxoSmithKline PLC
6.4.7.1 Company overview
6.4.7.2 Financial performance
6.4.7.3 Product benchmarking
6.4.7.4 Strategic initiatives
6.4.8 Merck and Co.
6.4.8.1 Company overview
6.4.8.2 Financial performance
6.4.8.3 Product benchmarking
6.4.8.4 Strategic initiatives
6.4.9 Pfizer
6.4.9.1 Company overview
6.4.9.2 Financial performance
6.4.9.3 Product benchmarking
6.4.9.4 Strategic initiatives
6.4.10 Sanofi
6.4.10.1 Company overview
6.4.10.2 Financial performance
6.4.10.3 Product benchmarking
6.4.10.4 Strategic initiatives
6.4.11 Samsung Electronics Co. Ltd.
6.4.11.1 Company overview
6.4.11.2 Financial performance
6.4.11.3 Product benchmarking
6.4.11.4 Strategic initiatives
6.4.12 Qualcomm Technologies, Inc.
6.4.12.1 Company overview
6.4.12.2 Financial performance
6.4.12.3 Product benchmarking
6.4.12.4 Strategic initiatives
6.4.13 Orange
6.4.13.1 Company overview
6.4.13.2 Financial performance
6.4.13.3 Product benchmarking
6.4.13.4 Strategic initiatives
6.4.14 Google, Inc.
6.4.14.1 Company overview
6.4.14.2 Financial performance
6.4.14.3 Product benchmarking
6.4.14.4 Strategic initiatives
6.4.15 Allscripts
6.4.15.1 Company overview
6.4.15.2 Financial performance
6.4.15.3 Product benchmarking
6.4.15.4 Strategic initiatives
6.4.16 Airstrip Technologies
6.4.16.1 Company overview
6.4.16.2 Financial performance
6.4.16.3 Product benchmarking
6.4.16.4 Strategic initiatives
6.4.17 AT&T
6.4.17.1 Company overview
6.4.17.2 Financial performance
6.4.17.3 Product benchmarking
6.4.17.4 Strategic initiatives
6.4.18 Apple, Inc
6.4.18.1 Company overview
6.4.18.2 Financial performance
6.4.18.3 Product benchmarking
6.4.18.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 North America telecare market, by type, 2016-2030 (USD Million)
Table 3 U.S. Telecare market, by Type, 2016-2030 (USD Million)
Table 4 Canada Telecare market, by Type, 2016-2030 (USD Million)
Table 5 Europe Telecare market, by Type, 2016-2030 (USD Million)
Table 6 U.K. Telecare market, by Type, 2016-2030 (USD Million)
Table 7 Germany Telecare market, by Type, 2016-2030 (USD Million)
Table 8 France Telecare market, by Type, 2016-2030 (USD Million)
Table 9 Italy Telecare market, by Type, 2016-2030 (USD Million)
Table 10 Spain Telecare market, by Type, 2016-2030 (USD Million)
Table 11 Russia Telecare market, by Type, 2016-2030 (USD Million)
Table 12 Asia Pacific Telecare market, by Type, 2016-2030 (USD Million)
Table 13 Japan Telecare market, by Type, 2016-2030 (USD Million)
Table 14 China Telecare market, by Type, 2016-2030 (USD Million)
Table 15 India Telecare market, by Type, 2016-2030 (USD Million)
Table 16 Australia Telecare market, by Type, 2016-2030 (USD Million)
Table 17 South Korea Telecare market, by Type, 2016-2030 (USD Million)
Table 18 Singapore Telecare market, by Type, 2016-2030 (USD Million)
Table 19 Latin America Telecare market, by Type, 2016-2030 (USD Million)
Table 20 Brazil Telecare market, by Type, 2016-2030 (USD Million)
Table 21 Mexico Telecare market, by Type, 2016-2030 (USD Million)
Table 22 Argentina Telecare market, by Type, 2016-2030 (USD Million)
Table 23 MEA Telecare market, by Type, 2016-2030 (USD Million)
Table 24 South Africa Telecare market, by Type, 2016-2030 (USD Million)
Table 25 Saudi Arabia Telecare market, by Type, 2016-2030 (USD Million)
Table 26 UAE Telecare market, by Type, 2016-2030 (USD Million)
List of Figures
Fig. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Telecare market outlook, 2021
FIG. 9 Telecare market segmentation
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Telecare type market share analysis, 2021 & 2030
FIG. 13 Telecare type market: Segment dashboard
FIG. 14 Activity monitoring market, 2016 - 2030 (USD Million)
FIG. 15 Remote medication management market, 2016 - 2030 (USD Million)
FIG. 16 Telecare regional market share analysis, 2021 & 2030
FIG. 17 Telecare regional market: Segment dashboard
FIG. 18 Regional market place: Key takeaways
FIG. 19 North America Telecare market: SWOT Analysis
FIG. 20 North America Telecare market, 2016 - 2030 (USD Million)
FIG. 21 U.S. Telecare market, 2016 - 2030 (USD Million)
FIG. 22 Canada Telecare market, 2016 - 2030 (USD Million)
FIG. 23 Europe Telecare market: SWOT Analysis
FIG. 24 Europe Telecare market, 2016 - 2030 (USD Million)
FIG. 25 U.K. Telecare market, 2016 - 2030 (USD Million)
FIG. 26 Germany Telecare market, 2016 - 2030 (USD Million)
FIG. 27 France Telecare market, 2016 - 2030 (USD Million)
FIG. 28 Italy Telecare market, 2016 - 2030 (USD Million)
FIG. 29 Spain Telecare market, 2016 - 2030 (USD Million)
FIG. 30 Russia Telecare market, 2016 - 2030 (USD Million)
FIG. 31 Asia Pacific Telecare market: SWOT Analysis
FIG. 32 Asia Pacific Telecare market, 2016 - 2030 (USD Million)
FIG. 33 Japan Telecare market, 2016 - 2030 (USD Million)
FIG. 34 China Telecare market, 2016 - 2030 (USD Million)
FIG. 35 India Telecare market, 2016 - 2030 (USD Million)
FIG. 36 Australia Telecare market, 2016 - 2030 (USD Million)
FIG. 37 South Korea Telecare market, 2016 - 2030 (USD Million)
FIG. 38 Singapore Telecare market, 2016 - 2030 (USD Million)
FIG. 39 Latin America Telecare market: SWOT Analysis
FIG. 40 Latin America Telecare market, 2016 - 2030 (USD Million)
FIG. 41 Brazil Telecare market, 2016 - 2030 (USD Million)
FIG. 42 Mexico Telecare market, 2016 - 2030 (USD Million)
FIG. 43 Argentina Telecare market, 2016 - 2030 (USD Million)
FIG. 44 MEA Telecare market: SWOT Analysis
FIG. 45 MEA Telecare market, 2016 - 2030 (USD Million)
FIG. 46 South Africa Telecare market, 2016 - 2030 (USD Million)
FIG. 47 Saudi Arabia Telecare market, 2016 - 2030 (USD Million)
FIG. 48 UAE Telecare market, 2016 - 2030 (USD Million)
FIG. 49 Company/competition categorization (Key innovators, market leaders, emerging players)
FIG. 50 Strategy framework
FIG. 51 Telecare competitive landscape: Market position analysis (based on products, regional presence, and recent updates)

Companies Mentioned

  • Abbott
  • Johnson and Johnson
  • Astrazeneca plc
  • Roche
  • Novartis
  • Bristol-Myers Squibb
  • GlaxoSmithKline plc
  • Merck and Co.
  • Pfizer
  • Sanofi
  • Samsung Electronics Co. Ltd.
  • Qualcomm Technologies, Inc.
  • Orange
  • Google, Inc.
  • Allscripts
  • Airstrip Technologies
  • At&T
  • Apple, Inc

Methodology

Loading
LOADING...